These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2652744)

  • 1. Lidocaine metabolism as an index of liver function in hepatic transplant donors and recipients.
    Schroeder TJ; Gremse DA; Mansour ME; Theuerling AW; Brunson ME; Ryckman FC; Suchy FJ; Penn I; Alexander JW; Pesce AJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2299-301. PubMed ID: 2652744
    [No Abstract]   [Full Text] [Related]  

  • 2. Histological comparison of donor livers and lidocaine metabolism in the utilization of organs for liver transplantation.
    Rosenlof LK; Sawyer RG; Broccoli AV; Ishitani MB; Stevenson WC; Pruett TL
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1662-3. PubMed ID: 8442229
    [No Abstract]   [Full Text] [Related]  

  • 3. Lignocaine metabolism and MEGX production in the liver transplant donor.
    Potter JM; Hickman PE; Balderson G; Lynch SV; Strong R
    Transplant Proc; 1992 Feb; 24(1):198-9. PubMed ID: 1539243
    [No Abstract]   [Full Text] [Related]  

  • 4. Lidocaine metabolite formation in the liver donor as a predictive test for the safe and efficient introduction of cyclosporine in the recipient.
    Azoulay D; Lemoine A; Gries JM; Adam R; Dolizy I; Fredj G; Beaune P; Bismuth H
    Transplant Proc; 1993 Jun; 25(3):2275-8. PubMed ID: 8516899
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of lidocaine as a test of liver function in liver transplantation.
    Potter JM; Oellerich M
    Liver Transpl Surg; 1996 May; 2(3):211-24. PubMed ID: 9346651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive evaluation of brain-dead donors for liver transplantation: personal experience.
    Bruzzone P; Alfani D; Rossi M; Bachetoni A; Berloco P; Casciaro G; Iappelli M; Carboni F; Marciani A; Cortesini R
    Transplant Proc; 1993 Jun; 25(3):2214-5. PubMed ID: 8516874
    [No Abstract]   [Full Text] [Related]  

  • 7. Donor rating in human liver transplantation: correlation of oxygen consumption after revascularization with MEGX formation in donors.
    Burdelski M; Oellerich M; Bornscheuer A; Luebbe N; Ringe B; Lamesch P; Raude E; Raith H; Scheruhn M; Gubernatis G
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2392-3. PubMed ID: 2652779
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatic lidocaine metabolism is useful in the selection of patients in need of liver transplantation.
    Luketic VA; Shiffman ML; Fisher RA; Sanyal AJ; Purdum PP; Posner MP
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1072-4. PubMed ID: 8442046
    [No Abstract]   [Full Text] [Related]  

  • 9. MEGX as a test of donor liver function.
    Balderson GA; Potter JM; Hickman PE; Chen Y; Lynch SV; Strong RW
    Transplant Proc; 1992 Oct; 24(5):1960-1. PubMed ID: 1412928
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dynamic liver function study using the lidocaine test].
    Sídlová K; Průsa R
    Cas Lek Cesk; 2000 Sep; 139(19):604-5. PubMed ID: 11192753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic lidocaine metabolism and liver histology.
    Fabbri A; Bianchi GP; Marchesini G
    Hepatology; 1995 Jun; 21(6):1761-2. PubMed ID: 7768525
    [No Abstract]   [Full Text] [Related]  

  • 12. Limits of the MEGX test in the selection of liver grafts for transplantation.
    Adam R; Azoulay D; Astarcioglu I; Chiche L; Bao YM; Bonhomme L; Lemoine A; Fredj G; Bismuth H
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1653-4. PubMed ID: 8442225
    [No Abstract]   [Full Text] [Related]  

  • 13. Monoethylglycinexylide formation in assessing pediatric donor liver function.
    Rossi SJ; Schroeder TJ; Vine WH; A-Kader HH; Gremse DA; Ryckman FC; Pedersen SH; Pesce AJ; Balistreri WF
    Ther Drug Monit; 1992 Dec; 14(6):452-6. PubMed ID: 1485364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional state of the donor liver and early outcome of transplantation.
    Oellerich M; Burdelski M; Ringe B; Wittekind C; Lamesch P; Lautz HU; Gubernatis G; Beyrau R; Pichlmayr R
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1575-8. PubMed ID: 1989297
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatic lidocaine metabolism and complications of cirrhosis. Implications for assessing patient priority for hepatic transplantation.
    Shiffman ML; Fisher RA; Sanyal AJ; Edinboro LE; Luketic VA; Purdum PP; Raymond P; Posner MP
    Transplantation; 1993 Apr; 55(4):830-5. PubMed ID: 8475560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor hyaluronic acid and MEGX levels do not accurately predict posttransplant liver function.
    Michell ID; Abdulnour I; Pzybylowski G; Bowkett J; Gleeson A; Hardy KJ; Jones RM
    Transplant Proc; 1993 Oct; 25(5):2888-9. PubMed ID: 8212275
    [No Abstract]   [Full Text] [Related]  

  • 17. The lidocaine monoethylglycinexylidide test of liver function.
    Ghent CN; Wall WJ
    Liver Transpl Surg; 1996 May; 2(3):242-5. PubMed ID: 9346657
    [No Abstract]   [Full Text] [Related]  

  • 18. Safe use of liver donors with MEGX values less than 90 ng/mL.
    Tesi RJ; Elkhammas EA; Davies EA; Salazar A; Henry ML; Greenson J; Ferguson RM
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1655-6. PubMed ID: 8442226
    [No Abstract]   [Full Text] [Related]  

  • 19. Selection criteria for liver transplant donors.
    Schroeder TJ; Pesce AJ; Ryckman FC; Tressler TP; Brunson ME; Pedersen SH; Tchervenkov JI; Penn I; Alexander JW; Balistreri WF
    J Clin Lab Anal; 1991; 5(4):275-7. PubMed ID: 1890541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of the monoethylglycinexylidide liver function test in assessing donor liver suitability.
    Fairchild R; Solomon H; Contis J; Kaminski D
    Arch Surg; 1996 Oct; 131(10):1099-102. PubMed ID: 8857911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.